Screener
SAB Biotherapeutics SABS Q2 2026 earnings
Reported August 6, 2026 · Before market open
EPS-$0.28Beat by $0.00
Revenue estimate$125.0K
EPS estimate-$0.28
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$125.0K
EPS estimate-$0.27
Versus estimates
Diluted EPS
FAQ
- When did SAB Biotherapeutics report Q2 2026 earnings?
- SAB Biotherapeutics (SABS) reported Q2 2026 earnings on August 6, 2026 before market open.
- What were SAB Biotherapeutics's Q2 2026 revenue and EPS?
- SAB Biotherapeutics reported eps of $-0.28 for Q2 2026.
- Did SAB Biotherapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.28 by $0.00.
- How did SAB Biotherapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 74.3% from $-1.09.
- Where can I find SAB Biotherapeutics's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-336783) directly on SEC EDGAR. The filing index links above go to sec.gov.
